microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites

Overview of attention for article published in Molecular Cancer Therapeutics, March 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

guideline: 1 clinical guideline source

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 20 Nov 2017

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.